# Wegovy is a semaglutide 2.4 mg once-weekly injectable medication.

*biotech · news · 2026-04-24 · The Manila Times*

## Key points

- Novo Nordisk has officially launched prescription-only Wegovy for obesity management in the Philippines.
- Wegovy contains a higher dose of semaglutide than Ozempic, specifically for obesity treatment.
- The economic cost of obesity in the Philippines is projected to reach P1.9 trillion by 2025.
- Wegovy's benefits include improved cardiometabolic health beyond just weight loss and appetite regulation.
- Wegovy will be available in Philippine drugstores but strictly requires a doctor's prescription.

**Companies:** Novo Nordisk
**Countries:** Philippines

[Read the full story on The Manila Times](https://www.manilatimes.net/2026/04/25/news/new-obesity-drug-launched/2328290)

---

Canonical: https://newsio.io/n/2af22fb5-7291-475d-b190-ad2058a46799/wegovy-is-a-semaglutide-2-4-mg-once-weekly-injectable-medication-it-mimics-the-g
Summarized by Newsio from The Manila Times. https://newsio.io/how-it-works